150 HIV Organizations Urge Continuation of D:A:D Study
150 organizations called on six pharmaceutical companies to continue funding the vital D:A:D study. 150 HIV Organizations Urge Continuation of D:A:D Study
Activists Urge CDC Withdraw Ebola Travel Restrictions for Asymptomatic People
We write as professionals, activists, and public health researchers who have worked to combat AIDS and other infectious diseases in the United States and around the world for over three decades.
Advocates Urge Governor Cuomo to Withdraw Mandatory Quarantine Order
Letter from TAG and others asking for withdrawal of mandatory quarantine requirement for entering the US through Newark and JFK airports who have had direct contact with individuals with Ebola Virus Disease in Guinea, Liberia, and Sierra Leone.
Activists Urge Governor Cuomo to Reject Proposed NYS Medicaid HCV Treatment Restrictions
Letter from TAG and other advocates expressing concerns about proposed Medicaid criteria that will limit access to sofosbuvir and other lifesaving hepatitis C medications.
Letters to Menigitis Vaccine Makers Urging Efficacy Studies in People with HIV
Letter asking to speak to key staff at Novartis to discuss its support of the clinical research required to more fully understand the efficacy of Menveo in adolescents and adults living with HIV.
Letter to Governor Cuomo on Ending AIDS in New York State
Follow-up to January 14, 2014 letter regarding the development of a plan to end AIDS in New York State.
Letter Urging AstraZeneca to Continue to Invest in TB Research
February 13, 2014 TAG, CRAG, and the TB CAB sent an open letter to AstraZeneca urging their continued investment in tuberculosis research despite the cessation of AstraZeneca’s Neglected Tropical Diseases, Tuberculosis, and Malaria Program. Read/Download the TAG, CRAG, TB CAB…
Open Letter: Appreciation for Sanofi US Committing to Lower Price of Rifapentine
This letter from CRAG (TB Community Research Advisors Group) and TAG was sent to Anne Whitaker, President, North America Pharmaceuticals of Sanofi US. It commends Sanofi for making this commitment to lower the price of rifapentine for Public Health Service…
TAG, CRAG, and TB CAB Letter Calling for Compassionate Use Program for Delamanid
TAG, CRAG, and the TB CAB issues urgent appeal for Otsuka to initiate its long overdue compassionate use program by the end of 2013.
Letter to Secretary Sebelius on ACA Allowance of Drug Co-Pay Programs
167 Organizations and 513 Individuals Signed on to Letter to Secretary Sebelius on the Allowance of Co-pay Assistance in the ACA Health Plans